RecruitingNot ApplicableNCT06168903

EOI Block Versus ESP Block in Laparoscopic Bariatric Surgery

External Oblique Intercostal Block Versus Erector Spinae Plane Block in Laparoscopic Bariatric Surgery: A Randomized Controlled Trial


Sponsor

Cairo University

Enrollment

50 participants

Start Date

Dec 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare a single shot of bilateral ultrasound-guided EOI block and ESPB in terms of intraoperative opioid consumption, postoperative pain control in the first 24 hours, and the need for rescue analgesics.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria1

  • Obese patients of any gender with a body mass index (BMI) of ≥ 35 kg/m2 with comorbidities or \> 40 kg/m2 and American Society of Anesthesiologists (ASA) physical status I-III and aged between 18 and 70 years scheduled for laparoscopic bariatric surgery, that is, sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgery.

Exclusion Criteria1

  • Coagulopathy, infection at the injection site, allergy to local anesthetics, severe hepatic or renal disease, severe cardiopulmonary disease (≥ ASA IV), diabetic or other neuropathies, patients receiving opioids for chronic analgesic therapy, and inability to comprehend visual analogue scale (VAS).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREUltrasound guided EOI block

Before receiving general anesthesia, patients will be randomly assigned to one of the two study groups: the EOI block group or the ESPB group. Using Ultrasound (Siemens ACUSON X300 Ultrasound System), guided blocks will be administered immediately after the induction of anesthesia and prior to surgical incision by consultant anesthesiologists who have experience in regional anesthesia and are familiar with the EOI and ESPB blocks


Locations(1)

Cairo university Hospitals. kasralainy

Cairo, Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06168903


Related Trials